2019 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
| Top rated | 12 of 50 | 
| Best rating | 159 % | 
| Worst rating | -420 % | 
| New companies | 6 | 
| Negative Economic Capital Ratio | 16 of 50 | 
Financial Strength Rankings using Artificial Intelligence
| Top rated | 12 of 50 | 
| Best rating | 159 % | 
| Worst rating | -420 % | 
| New companies | 6 | 
| Negative Economic Capital Ratio | 16 of 50 | 
TAURIGA SCIENCES INC. climbed 22 positions from 47 to 25 due to its excellent Net Income.Navidea Biopharmaceuticals Inc. lost 45 positions from 1 to 46 due to its bad Net Income.Huntsman CORP entered the 2019 ranking at rank 19, making it the best newcomer.
| Revenues | 41.6 B | 
| Assets | 55.1 B | 
| Expenses | 38.6 B | 
| Stockholders Equity | 22.6 B | 
| Unprofitable Companies | 28 of 50 | 

This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai